Neologics Biosci 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NB002 / Neologics Biosci
NCT05924906: A Dose Escalation and Expansion Study of NB002 in Participants With Advanced or Metastatic Solid Tumors

Not yet recruiting
1a/1b
30
NA
NB002
Suzhou Neologics Bioscience Co., Ltd.
Advanced Solid Tumor
04/26
07/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NB002 / Neologics Biosci
NCT05924906: A Dose Escalation and Expansion Study of NB002 in Participants With Advanced or Metastatic Solid Tumors

Not yet recruiting
1a/1b
30
NA
NB002
Suzhou Neologics Bioscience Co., Ltd.
Advanced Solid Tumor
04/26
07/26

Download Options